133 related articles for article (PubMed ID: 31685775)
1. Dosing Time-Dependent Changes in the Anti-tumor Effect of xCT Inhibitor Erastin in Human Breast Cancer Xenograft Mice.
Shiromizu S; Yamauchi T; Kusunose N; Matsunaga N; Koyanagi S; Ohdo S
Biol Pharm Bull; 2019; 42(11):1921-1925. PubMed ID: 31685775
[TBL] [Abstract][Full Text] [Related]
2. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells.
Yu M; Gai C; Li Z; Ding D; Zheng J; Zhang W; Lv S; Li W
Cancer Sci; 2019 Oct; 110(10):3173-3182. PubMed ID: 31464035
[TBL] [Abstract][Full Text] [Related]
3. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function.
Chen L; Li X; Liu L; Yu B; Xue Y; Liu Y
Oncol Rep; 2015 Mar; 33(3):1465-74. PubMed ID: 25585997
[TBL] [Abstract][Full Text] [Related]
4. Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo.
Shibata Y; Yasui H; Higashikawa K; Miyamoto N; Kuge Y
PLoS One; 2019; 14(12):e0225931. PubMed ID: 31800616
[TBL] [Abstract][Full Text] [Related]
5. Genetic Ablation of the Cystine Transporter xCT in PDAC Cells Inhibits mTORC1, Growth, Survival, and Tumor Formation via Nutrient and Oxidative Stresses.
Daher B; Parks SK; Durivault J; Cormerais Y; Baidarjad H; Tambutte E; Pouysségur J; Vučetić M
Cancer Res; 2019 Aug; 79(15):3877-3890. PubMed ID: 31175120
[TBL] [Abstract][Full Text] [Related]
6. Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis.
Sehm T; Rauh M; Wiendieck K; Buchfelder M; Eyüpoglu IY; Savaskan NE
Oncotarget; 2016 Nov; 7(46):74630-74647. PubMed ID: 27612422
[TBL] [Abstract][Full Text] [Related]
7. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
Roh JL; Kim EH; Jang HJ; Park JY; Shin D
Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
[TBL] [Abstract][Full Text] [Related]
8. The viability of primary hepatocytes is maintained under a low cysteine-glutathione redox state with a marked elevation in ophthalmic acid production.
Lee J; Kang ES; Kobayashi S; Homma T; Sato H; Seo HG; Fujii J
Exp Cell Res; 2017 Dec; 361(1):178-191. PubMed ID: 29079265
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.
Lien EC; Ghisolfi L; Geck RC; Asara JM; Toker A
Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259101
[TBL] [Abstract][Full Text] [Related]
10. d-Cysteine supplementation partially protects against ferroptosis induced by xCT dysfunction via increasing the availability of glutathione.
Homma T; Osaki T; Kobayashi S; Sato H; Fujii J
J Clin Biochem Nutr; 2022 Jul; 71(1):48-54. PubMed ID: 35903611
[TBL] [Abstract][Full Text] [Related]
11. Optimizing the dosing schedule of l-asparaginase improves its anti-tumor activity in breast tumor-bearing mice.
Shiromizu S; Kusunose N; Matsunaga N; Koyanagi S; Ohdo S
J Pharmacol Sci; 2018 Apr; 136(4):228-233. PubMed ID: 29605274
[TBL] [Abstract][Full Text] [Related]
12. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth.
Cramer SL; Saha A; Liu J; Tadi S; Tiziani S; Yan W; Triplett K; Lamb C; Alters SE; Rowlinson S; Zhang YJ; Keating MJ; Huang P; DiGiovanni J; Georgiou G; Stone E
Nat Med; 2017 Jan; 23(1):120-127. PubMed ID: 27869804
[TBL] [Abstract][Full Text] [Related]
13. xCT deficiency aggravates acetaminophen-induced hepatotoxicity under inhibition of the transsulfuration pathway.
Kang ES; Lee J; Homma T; Kurahashi T; Kobayashi S; Nabeshima A; Yamada S; Seo HG; Miyata S; Sato H; Fujii J
Free Radic Res; 2017 Jan; 51(1):80-90. PubMed ID: 28081640
[TBL] [Abstract][Full Text] [Related]
14. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
Hasegawa M; Takahashi H; Rajabi H; Alam M; Suzuki Y; Yin L; Tagde A; Maeda T; Hiraki M; Sukhatme VP; Kufe D
Oncotarget; 2016 Mar; 7(11):11756-69. PubMed ID: 26930718
[TBL] [Abstract][Full Text] [Related]
15. Upregulation and activation of p53 by erastin‑induced reactive oxygen species contribute to cytotoxic and cytostatic effects in A549 lung cancer cells.
Huang C; Yang M; Deng J; Li P; Su W; Jiang R
Oncol Rep; 2018 Oct; 40(4):2363-2370. PubMed ID: 30066882
[TBL] [Abstract][Full Text] [Related]
16. Novel mouse model for evaluating in vivo efficacy of xCT inhibitor.
Yoshioka R; Fujieda Y; Suzuki Y; Kanno O; Nagahira A; Honda T; Murakawa M; Yukiura H
J Pharmacol Sci; 2019 Jul; 140(3):242-247. PubMed ID: 31421954
[TBL] [Abstract][Full Text] [Related]
17. Superoxide produced by mitochondrial complex III plays a pivotal role in the execution of ferroptosis induced by cysteine starvation.
Homma T; Kobayashi S; Sato H; Fujii J
Arch Biochem Biophys; 2021 Mar; 700():108775. PubMed ID: 33493440
[TBL] [Abstract][Full Text] [Related]
18. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
19. Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.
Linher-Melville K; Nashed MG; Ungard RG; Haftchenary S; Rosa DA; Gunning PT; Singh G
PLoS One; 2016; 11(8):e0161202. PubMed ID: 27513743
[TBL] [Abstract][Full Text] [Related]
20. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
Habib E; Linher-Melville K; Lin HX; Singh G
Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
